GB201708779D0 - Virus and method - Google Patents

Virus and method

Info

Publication number
GB201708779D0
GB201708779D0 GBGB1708779.2A GB201708779A GB201708779D0 GB 201708779 D0 GB201708779 D0 GB 201708779D0 GB 201708779 A GB201708779 A GB 201708779A GB 201708779 D0 GB201708779 D0 GB 201708779D0
Authority
GB
United Kingdom
Prior art keywords
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1708779.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psioxus Therapeutics Ltd
Original Assignee
Psioxus Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psioxus Therapeutics Ltd filed Critical Psioxus Therapeutics Ltd
Priority to GBGB1708779.2A priority Critical patent/GB201708779D0/en
Publication of GB201708779D0 publication Critical patent/GB201708779D0/en
Priority to CA3063652A priority patent/CA3063652A1/en
Priority to CN201880035279.3A priority patent/CN111246867B/en
Priority to EP23170353.9A priority patent/EP4269438A3/en
Priority to HRP20230812TT priority patent/HRP20230812T1/en
Priority to US16/618,068 priority patent/US11142580B2/en
Priority to JP2019566331A priority patent/JP7394628B2/en
Priority to HUE18732263A priority patent/HUE063274T2/en
Priority to IL270989A priority patent/IL270989B2/en
Priority to DK18732263.1T priority patent/DK3630143T3/en
Priority to PCT/EP2018/064524 priority patent/WO2018220207A1/en
Priority to BR112019024918-4A priority patent/BR112019024918A2/en
Priority to AU2018277294A priority patent/AU2018277294A1/en
Priority to EA201992401A priority patent/EA201992401A1/en
Priority to PL18732263.1T priority patent/PL3630143T3/en
Priority to SI201830980T priority patent/SI3630143T1/en
Priority to LTEPPCT/EP2018/064524T priority patent/LT3630143T/en
Priority to FIEP18732263.1T priority patent/FI3630143T3/en
Priority to MYPI2019006893A priority patent/MY197684A/en
Priority to ES18732263T priority patent/ES2952601T3/en
Priority to KR1020197038939A priority patent/KR20200026835A/en
Priority to MX2019014184A priority patent/MX2019014184A/en
Priority to PT187322631T priority patent/PT3630143T/en
Priority to EP18732263.1A priority patent/EP3630143B1/en
Priority to ZA2019/07351A priority patent/ZA201907351B/en
Priority to PH12019502522A priority patent/PH12019502522A1/en
Priority to CL2019003393A priority patent/CL2019003393A1/en
Priority to CONC2019/0013220A priority patent/CO2019013220A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10371—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB1708779.2A 2017-06-01 2017-06-01 Virus and method Ceased GB201708779D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GBGB1708779.2A GB201708779D0 (en) 2017-06-01 2017-06-01 Virus and method
EP18732263.1A EP3630143B1 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
AU2018277294A AU2018277294A1 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
PL18732263.1T PL3630143T3 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
EP23170353.9A EP4269438A3 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
HRP20230812TT HRP20230812T1 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
US16/618,068 US11142580B2 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
JP2019566331A JP7394628B2 (en) 2017-06-01 2018-06-01 Oncolytic viruses and methods
HUE18732263A HUE063274T2 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
IL270989A IL270989B2 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
DK18732263.1T DK3630143T3 (en) 2017-06-01 2018-06-01 ONCOLYTIC VIRUS AND METHOD
PCT/EP2018/064524 WO2018220207A1 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
BR112019024918-4A BR112019024918A2 (en) 2017-06-01 2018-06-01 ONCOLYTIC VIRUS AND METHOD
CA3063652A CA3063652A1 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
EA201992401A EA201992401A1 (en) 2017-06-01 2018-06-01 ONCOLITIC VIRUS AND METHOD
CN201880035279.3A CN111246867B (en) 2017-06-01 2018-06-01 Oncolytic viruses and methods
SI201830980T SI3630143T1 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
LTEPPCT/EP2018/064524T LT3630143T (en) 2017-06-01 2018-06-01 Oncolytic virus and method
FIEP18732263.1T FI3630143T3 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
MYPI2019006893A MY197684A (en) 2017-06-01 2018-06-01 Oncolytic virus and method
ES18732263T ES2952601T3 (en) 2017-06-01 2018-06-01 Oncolytic virus and method
KR1020197038939A KR20200026835A (en) 2017-06-01 2018-06-01 Oncolytic viruses and methods
MX2019014184A MX2019014184A (en) 2017-06-01 2018-06-01 Oncolytic virus and method.
PT187322631T PT3630143T (en) 2017-06-01 2018-06-01 Oncolytic virus and method
ZA2019/07351A ZA201907351B (en) 2017-06-01 2019-11-05 Oncolytic virus and method
PH12019502522A PH12019502522A1 (en) 2017-06-01 2019-11-11 Oncolytic virus and method
CL2019003393A CL2019003393A1 (en) 2017-06-01 2019-11-21 Oncolytic viruses and method.
CONC2019/0013220A CO2019013220A2 (en) 2017-06-01 2019-11-26 Oncolytic viruses and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1708779.2A GB201708779D0 (en) 2017-06-01 2017-06-01 Virus and method

Publications (1)

Publication Number Publication Date
GB201708779D0 true GB201708779D0 (en) 2017-07-19

Family

ID=59350018

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1708779.2A Ceased GB201708779D0 (en) 2017-06-01 2017-06-01 Virus and method

Country Status (2)

Country Link
EA (1) EA201992401A1 (en)
GB (1) GB201708779D0 (en)

Also Published As

Publication number Publication date
EA201992401A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
ZA201900535B (en) Blockchain implemented method and system
SG10202107633XA (en) Blockchain-implemented method and system
SG10202107632SA (en) Blockchain-implemented method and system
GB201719944D0 (en) Parking-lot-navigation system and method
GB2563925B (en) System and method
GB201900330D0 (en) Assembly and method
GB201805021D0 (en) Method and use
SG11202003088RA (en) Biocementation method and system
GB201805103D0 (en) Method and use
GB201805024D0 (en) Method and use
GB201805042D0 (en) Method and use
IL270989A (en) Oncolytic virus and method
GB2559889B (en) System and method
GB201717821D0 (en) System and method
GB201802171D0 (en) System and method
GB201703414D0 (en) Securing arrangement and method
GB201604012D0 (en) Refridgeration system and method
GB201620926D0 (en) Method and system
GB2582491B (en) Method and system
GB201616123D0 (en) System and method
GB201708779D0 (en) Virus and method
GB201708778D0 (en) Virus and method
GB2557734B (en) Assembly and method
GB201809605D0 (en) System and method
SG11202000935SA (en) Cis-polycycloolefins and methods for forming cis-polycycloolefins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)